SN-38

Results: 11



#Item
138/SN-206/ME XXIII. GP - Stellungnahme zum Entwurf elektronisch übermittelt 1 von 4 Universitätsrat Mag. Max Kothbauer

38/SN-206/ME XXIII. GP - Stellungnahme zum Entwurf elektronisch übermittelt 1 von 4 Universitätsrat Mag. Max Kothbauer

Add to Reading List

Source URL: universitaetsrat.univie.ac.at

Language: German - Date: 2012-02-08 05:26:41
    2B Business C Care C Consulting ------------------------------57 rue de la FaisanderieParis – France Mobile: Tel: 38 81

    B Business C Care C Consulting ------------------------------57 rue de la FaisanderieParis – France Mobile: Tel: 38 81

    Add to Reading List

    Source URL: www.centif.sn

    Language: French - Date: 2015-06-06 10:30:17
      338/SN-19/ME XXV. GP - Stellungnahme zu Entwurf (elektr. übermittelte Version) www.parlament.gv.at 1 von 2

      38/SN-19/ME XXV. GP - Stellungnahme zu Entwurf (elektr. übermittelte Version) www.parlament.gv.at 1 von 2

      Add to Reading List

      Source URL: www.parlament.gv.at

      - Date: 2014-05-09 03:48:08
        438+((1-2+7$-$13bb7(/0b7 %$5&(/21$1[removed]$1[removed] -$0$$/,6.887$ SN[removed]REV 1

        38+((1-2+7$-$13bb7(/0b7 %$5&(/21$1[removed]$1[removed] -$0$$/,6.887$ SN[removed]REV 1

        Add to Reading List

        Source URL: www.consilium.europa.eu

        Language: Finnish - Date: 2002-06-20 03:32:25
          5Topic 1. Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism Camptosar (Irinotecan hydrochloride injection) received accelerated approval on June 14, 1996 for the treatment of patients with

          Topic 1. Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism Camptosar (Irinotecan hydrochloride injection) received accelerated approval on June 14, 1996 for the treatment of patients with

          Add to Reading List

          Source URL: www.fda.gov

          Language: English - Date: 2004-10-14 14:44:53
          6Prodrugs / Irinotecan / Lactams / Lactones / Piperidines / Organic chemistry / SN-38 / UDP glucuronosyltransferase 1 family / polypeptide A1 / Pharmacogenetics / Pharmacology / Pharmacy / Medicine

          Topic 1. Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism Camptosar (Irinotecan hydrochloride injection) received accelerated approval on June 14, 1996 for the treatment of patients with

          Add to Reading List

          Source URL: www.fda.gov

          Language: English - Date: 2004-10-14 14:44:53
          738+((1-2+7$-$13bb7(/0b7 %$5&(/21$1[removed]$1[removed] -$0$$/,6.887$ SN[removed]REV 1

          38+((1-2+7$-$13bb7(/0b7 %$5&(/21$1[removed]$1[removed] -$0$$/,6.887$ SN[removed]REV 1

          Add to Reading List

          Source URL: www.consilium.europa.eu

          Language: Finnish - Date: 2002-06-20 03:32:25
            8Event Time: Precinct: Sn # : Ballot Image #: 07:13:38

            Event Time: Precinct: Sn # : Ballot Image #: 07:13:38

            Add to Reading List

            Source URL: election.dos.state.fl.us

            Language: English - Date: 2007-01-29 09:25:43
              91 2 CAMPTOSAR® irinotecan hydrochloride injection

              1 2 CAMPTOSAR® irinotecan hydrochloride injection

              Add to Reading List

              Source URL: www.accessdata.fda.gov

              Language: English - Date: 2009-03-31 16:09:01
              10Oncology: A Decade of Progress from Pharmacokinetics to Pharmacogenomics

              Oncology: A Decade of Progress from Pharmacokinetics to Pharmacogenomics

              Add to Reading List

              Source URL: www.fda.gov

              Language: English